0001209191-23-040287.txt : 20230630
0001209191-23-040287.hdr.sgml : 20230630
20230630160032
ACCESSION NUMBER: 0001209191-23-040287
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230628
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meeker David P
CENTRAL INDEX KEY: 0001385155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38886
FILM NUMBER: 231061556
MAIL ADDRESS:
STREET 1: C/O PENWEST PHARMACEUTICALS CO
STREET 2: 39 OLD RIDGEBURY ROAD SUITE 11
CITY: DANBURY
STATE: CT
ZIP: 06810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trevi Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450834299
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-304-2499
MAIL ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-28
0
0001563880
Trevi Therapeutics, Inc.
TRVI
0001385155
Meeker David P
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 16TH FLOOR
NEW HAVEN
CT
06510
1
0
0
0
0
Nonstatutory Stock Option (right to buy)
2.27
2023-06-28
4
A
0
30000
0.00
A
2033-06-27
Common Stock
30000
30000
D
This option was granted on June 28, 2023. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.
/s/ Christopher Galletta, attorney-in-fact
2023-06-30